MSD is taking an action in the direction of the financially rewarding excessive weight market with the purchase of a prospect based upon the GLP-1 hormonal agent.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/msd-inks-billion-dollar-deal-with-chinese-biotech-company-for-oral-weight-loss-drug/